Man Group’s Nuvation Bio NUVB Stock Holding History

Man Group’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33M	Sell	410,584 -221,654	-35%	-$1.08M	﹤0.01%	1501
2026 Q1	$2.71M	Buy	+632,238	New	+$3.52M	﹤0.01%	1432
2025 Q4	–	Sell	-89,357	Closed	-$331K	–	2403
2025 Q3	$331K	Buy	89,357 +50,744	+131%	+$138K	﹤0.01%	1973
2025 Q2	$75.3K	Buy	+38,613	New	+$80.4K	﹤0.01%	2130
2024 Q3	–	Sell	-110,626	Closed	-$323K	–	2128
2024 Q2	$323K	Sell	110,626 -149,653	-57%	-$457K	﹤0.01%	1773
2024 Q1	$947K	Buy	260,279 +21,949	+9%	+$42.1K	﹤0.01%	1561
2023 Q4	$360K	Buy	+238,330	New	+$307K	﹤0.01%	1772
2022 Q4	–	Sell	-55,100	Closed	-$123K	–	2139
2022 Q3	$123K	Buy	+55,100	New	+$157K	﹤0.01%	1839
2022 Q2	–	Sell	-14,500	Closed	-$63.2K	–	1853
2022 Q1	$76K	Buy	+14,500	New	+$81.5K	﹤0.01%	2087

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Man Group's NUVB Position: Q2 2026 in Review

Man Group reduced its Nuvation Bio (NUVB) stake by 35% in Q2 2026, selling an estimated $1.08M and leaving 410,584 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Man Group first reported a position in NUVB in Q1 2022 and has held it in 9 quarters since. The position peaked at $2.71M in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Man Group held 410,584 shares of Nuvation Bio worth $2.33M as of Q2 2026.
Man Group sold 221,654 Nuvation Bio shares in Q2 2026, an estimated $1.08M.
Nuvation Bio made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1501 holding.
Man Group first reported a position in Nuvation Bio in Q1 2022 and has held it in 9 quarters since.
Man Group's Nuvation Bio position peaked at $2.71M in Q1 2026.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.